Pendal Group LTD Bio Techne Corp Transaction History

Pendal Group LTD

$12.2 Billion
Q4 2022

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 25, 2022	SELL	$322.67 - $449.65 $175,532 - $244,609	-544 Closed	0 $0
Q1 2022 Apr 25, 2022	SELL	$353.85 - $487.79 $328,018 - $452,181	-927 Reduced 63.02%	544 $236,000
Q4 2021 Jan 18, 2022	BUY	$456.15 - $525.06 $12,772 - $14,701	28 Added 1.94%	1,471 $761,000
Q3 2021 Nov 05, 2021	SELL	$444.87 - $538.88 $349,667 - $423,559	-786 Reduced 35.26%	1,443 $699,000
Q2 2021 Jul 28, 2021	BUY	$387.35 - $450.26 $173,145 - $201,266	447 Added 25.08%	2,229 $1 Million
Q1 2021 May 24, 2021	BUY	$314.62 - $411.0 $560,652 - $732,402	1,782 New	1,782 $681,000
Q1 2021 May 03, 2021	SELL	$314.62 - $411.0 $553,731 - $723,360	-1,760 Closed	0 $0
Q3 2020 Nov 02, 2020	BUY	$232.22 - $282.96 $16,255 - $19,807	70 Added 4.14%	1,760 $436,000
Q2 2020 Aug 07, 2020	SELL	$185.43 - $279.56 $84,741 - $127,758	-457 Reduced 21.29%	1,690 $446,000
Q1 2020 May 04, 2020	BUY	$161.17 - $221.51 $37,552 - $51,611	233 Added 12.17%	2,147 $407,000
Q4 2019 Feb 06, 2020	SELL	$189.68 - $222.09 $405,725 - $475,050	-2,139 Reduced 52.78%	1,914 $420,000
Q3 2019 Nov 12, 2019	SELL	$183.56 - $216.72 $109,768 - $129,598	-598 Reduced 12.86%	4,053 $793,000
Q2 2019 Aug 01, 2019	SELL	$188.72 - $215.43 $66,618 - $76,046	-353 Reduced 7.05%	4,651 $0
Q1 2019 May 01, 2019	BUY	$136.09 - $200.44 $49,400 - $72,759	363 Added 7.82%	5,004 $0
Q4 2018 Jan 30, 2019	BUY	$132.75 - $203.8 $95,181 - $146,124	717 Added 18.27%	4,641 $671,000
Q3 2018 Nov 05, 2018	SELL	$147.44 - $204.11 $25,654 - $35,515	-174 Reduced 4.25%	3,924 $0
Q2 2018 Jul 18, 2018	BUY	$144.9 - $165.58 $251,401 - $287,281	1,735 Added 73.42%	4,098 $0
Q1 2018 May 08, 2018	BUY	$131.46 - $151.04 $310,639 - $356,907	2,363 New	2,363 $0

Others Institutions Holding TECH

# of Institutions

602

Shares Held

151M

Call Options Held

195K

Put Options Held

53.2K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.86B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pendal Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Pendal Group LTD with notifications on news.

Account